Apellis Pharmaceuticals, Inc.【APLS】 研究開発費の推移

機能の使い方
(単位:千ドル) 研究開発費 前年比(%)
4Q25 74,233 -2.8%
3Q25 68,186 -23.0%
2Q25 67,015 -14.0%
1Q25 86,420 +2.0%
4Q24 76,354 +10.2%
3Q24 88,569 +11.5%
2Q24 77,947 -18.5%
1Q24 84,701 -23.0%
4Q23 69,282 -30.3%
3Q23 79,421 -16.6%
2Q23 95,658 -5.9%
1Q23 110,027 +21.0%
4Q22 99,423 +27.2%
3Q22 95,207 +8.5%
2Q22 101,661 +6.0%
1Q22 90,945 +8.3%
4Q21 78,181 +55.3%
3Q21 87,733 -5.9%
2Q21 95,943 +10.2%
1Q21 84,012 +21.3%
4Q20 50,337 -35.9%
3Q20 93,207 +81.6%
2Q20 87,094 +71.8%
1Q20 69,282 +71.2%
4Q19 78,471 +154.7%
3Q19 51,319 +73.7%
2Q19 50,698 +84.1%
1Q19 40,479 +132.6%
4Q18 30,805 -
3Q18 29,539 +210.4%
2Q18 27,537 -
1Q18 17,402 -
3Q17 9,517 -